Analysts Anticipate Concord Medical Services Hldg Ltd (CCM) to Announce $0.00 EPS

Shares of Concord Medical Services Hldg Ltd (NYSE:CCM) have received a consensus broker rating score of 3.70 (Sell) from the one brokers that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a sell recommendation.

Brokerages have set a 12-month consensus price target of $3.00 for the company, according to Zacks. Zacks has also assigned Concord Medical Services an industry rank of 94 out of 256 based on the ratings given to related companies.

NYSE CCM traded down $0.08 during trading hours on Thursday, reaching $2.45. The company’s stock had a trading volume of 3,000 shares, compared to its average volume of 7,762. The stock has a market cap of $101.47 million, a price-to-earnings ratio of -2.40 and a beta of 0.04. Concord Medical Services has a fifty-two week low of $2.30 and a fifty-two week high of $4.20.

A hedge fund recently raised its stake in Concord Medical Services stock. Wedbush Securities Inc. boosted its holdings in Concord Medical Services Hldg Ltd (NYSE:CCM) by 28.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 21,432 shares of the company’s stock after acquiring an additional 4,757 shares during the period. Wedbush Securities Inc.’s holdings in Concord Medical Services were worth $60,000 as of its most recent filing with the Securities and Exchange Commission. 1.77% of the stock is currently owned by institutional investors and hedge funds.

About Concord Medical Services

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services.

See Also: What is an overbought condition?

Get a free copy of the Zacks research report on Concord Medical Services (CCM)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with's FREE daily email newsletter.